Solutions

Case Studies

News > Salk Institute v. Ligand Pharmaceuticals

Salk Institute v. Ligand Pharmaceuticals

Summary:

Breach of Contract – settlement before arbitration
Cooley, LLP

$13 million settlement resolved several issues between the companies, the most significant relating to the sale of an anti-cancer drug to a third party.

Legal Arts role: Prepare a comprehensive technology tutorial related to chemical composition and properties of the anti-cancer drug Targretin.

Sign Up Now: